ANGIE DUKES: Open Payments
NPI 1083349435 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 25 payments from 14 companies in 2025. Trend: 2023 $787 · 2024 $813 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $215 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| PFIZER INC. | 1 | $116 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $113 |
| ABBVIE INC. | 1 | $111 |
| Gilead Sciences, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $41 |
| Exact Sciences Corporation | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Sage Therapeutics, LLC | 2 | $29 |
Products named: CAPLYTA, JARDIANCE, NURTEC ODT, JOURNAVX, VRAYLAR, MOUNJARO, BREZTRI, ZURZUVAE.
Industry payments across LA — which companies pay providers there.
